スポンサーリンク
Genzyme Corporation | 論文
- BP-K2 Developing new technologies for continuous manufacturing of recombinant proteins : When to innovate? What are the barriers? What are the challenges?(Section II Biopharmaceuticals Production)
- Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid α-glucosidase"
- Removal of necrotic tissue with an ananain-based enzyme-debriding preparation
- Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine
- Reducing glycosphingolipid biosynthesis in airway cells partially ameliorates disease manifestations in a mouse model of asthma
- Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity